ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 908,00
0,88%
DAX
18 869,36
0,78%
Brent Oil
82,655
0,13%
Bitcoin
66 108,53
7,41%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) Actualités

HZNP Horizon Therapeutics Public Limited Company

116,30
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Horizon Therapeutics Public Limited Company HZNP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 116,30 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
116,30 116,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/10/202322:44EDGAR2Form 15-12G - Securities registration termination [Section..
09/10/202313:33IHMARKETNEWSMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers,..
07/10/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202300:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202322:30EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/10/202322:05EDGAR2Form 8-K - Current report
06/10/202314:30BWRule 17(e) Announcement - Horizon Therapeutics plc
05/10/202313:40BWRule 17(d) Announcement – Horizon Therapeutics plc
05/10/202313:32EDGAR2Form 8-K - Current report
03/10/202317:15BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
03/10/202317:06BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202317:39BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202317:24BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202314:00BWHorizon Therapeutics plc Announces New UPLIZNA®..
29/9/202317:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
29/9/202316:00BWNew Analysis Highlights Importance of Adhering to..
27/9/202315:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
26/9/202315:02BWHorizon Therapeutics plc Named to U.S. News & World Report’s..
25/9/202315:34BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
19/9/202314:00BWHorizon Therapeutics plc Ranks Number One on the Fortune..
13/9/202314:00PRNUSQ32 Bio and Horizon Therapeutics plc Announce Dosing of..
12/9/202313:30EDGAR2Form 8-K - Current report
06/9/202322:15BWHorizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement
06/9/202313:20IHMARKETNEWSWednesday’s Wall Street Highlights: Verb Technology, Apple,..
05/9/202315:09EDGAR2Form 8-K - Current report
05/9/202315:05BWHorizon Therapeutics Announces Date of Irish Court Hearing..
01/9/202320:46DJNTrending: FTC Ends Challenge of Amgen/Horizon Deal
01/9/202315:21EDGAR2Form 8-K - Current report
01/9/202315:20BWAmgen and Horizon Therapeutics plc Resolve FTC Lawsuit,..
28/8/202315:06IHMARKETNEWSMonday’s Wall Street Highlights: Jabil, Xpeng, 3M, Hostess..
28/8/202310:24DJFRLa FTC suspend son recours contre le rachat de Horizon..
23/8/202314:00BWHorizon Therapeutics plc Ranks First in Overall Corporate..
09/8/202316:30BWHorizon Therapeutics plc - Rule 2.12 Announcement
08/8/202314:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:11EDGAR2Form 8-K - Current report
08/8/202313:00BWHorizon Therapeutics plc Reports Second-Quarter 2023..
28/7/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202322:10EDGAR2Form 8-K - Current report
28/7/202317:55BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202317:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202317:35BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202317:30BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202317:20BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

Dernières Valeurs Consultées

NASDAQ
HZNP
Horizon Therapeutics Pub...
LSE
0QM1
Schlatter Industries
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés